FDA Approves Ferring Pharmaceuticals' Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer Dec 25, 2008
Lupron Depot(R) (leuprolide acetate for depot suspension) is a registered trademark of TAP Pharmaceuticals Inc.. SOURCE Ferring Pharmaceuticals Inc.. (PR Newswire)
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc. Aug 26, 2008
"We are extremely excited to announce this transaction for our third non-core asset, Atrigel. This licensing deal will bring our total proceeds from our announced non-core asset transactions to approximately US$240 million," said Bob Butchofsky, President and Chief Executive Officer of QLT. "We have worked diligently towards streamlining the Company and believe we are close to reaching this goal. Eligard, our leuprolide acetate for injectable suspension for the palliative treatment of advanced... (PR Newswire)
Takeda and Tap to promote Sucampo's Amitiza in the United States Feb 27, 2007
TAP markets Prevacid (lansoprazole) and Lupron Depot (leuprolide acetate for depot suspension). For more information about TAP Pharmaceutical Products, Inc., and its products, visit the company's Web site at. (EurekAlert! -- Business News)
